Part 1) I took part in the Roche GENERATION-HD1 clinical trial evaluating the efficacy of the huntingtin-lowering drug, tominersen, for patients with Huntingtons Disease. After the trial had concluded, I found out that I was on the active drug (rather than the placebo). I'm not surprised as I really felt that my HD symptoms have improved considerably while on (and since) the trial.

en.hdbuzz.net/354